RATIONALE: Methylphenidate (MPH), the most widely prescribed psychostimulant to treat many neuropsychiatric conditions, is reported to improve attention and speed of processing in survivors of traumatic brain injury (TBI). The neural correlate of this efficacy, however, remains unclear. OBJECTIVE: Using perfusion functional magnetic resonance imaging (fMRI) as a biomarker of regional neural activity, the current study aimed to examine the neural correlates of single-dose (0.3 mg/kg) MPH administration in a randomized double-blind placebo-controlled crossover study design. METHODS:Twenty-three individuals with moderate to severe TBI were tested on two occasions approximately 1 week apart. Perfusion fMRI scanning was carried out at rest and while participants performed cognitive tasks requiring sustained attention and working memory. RESULTS: Behaviorally, MPH significantly improved both accuracy and reaction time (RT) in the sustained attention task but only RT in the working memory task. A trend of global reduction of cerebral blood flow by MPH was observed in all task conditions including resting. Voxel-wise whole-brain analysis revealed an interaction effect of drug by condition (MPH-placebo X task-rest) for the sustained attention task in the left posterior superior parietal cortex and parieto-occipital junction (BA 7/19). The magnitude of drug-related deactivation of this area during task performance was correlated with improvement in RT. CONCLUSION: Suppression of activity in this area during task performance may reflect a compensatory mechanism by which MPH ameliorates attention impairments in TBI.
RCT Entities:
RATIONALE: Methylphenidate (MPH), the most widely prescribed psychostimulant to treat many neuropsychiatric conditions, is reported to improve attention and speed of processing in survivors of traumatic brain injury (TBI). The neural correlate of this efficacy, however, remains unclear. OBJECTIVE: Using perfusion functional magnetic resonance imaging (fMRI) as a biomarker of regional neural activity, the current study aimed to examine the neural correlates of single-dose (0.3 mg/kg) MPH administration in a randomized double-blind placebo-controlled crossover study design. METHODS: Twenty-three individuals with moderate to severe TBI were tested on two occasions approximately 1 week apart. Perfusion fMRI scanning was carried out at rest and while participants performed cognitive tasks requiring sustained attention and working memory. RESULTS: Behaviorally, MPH significantly improved both accuracy and reaction time (RT) in the sustained attention task but only RT in the working memory task. A trend of global reduction of cerebral blood flow by MPH was observed in all task conditions including resting. Voxel-wise whole-brain analysis revealed an interaction effect of drug by condition (MPH-placebo X task-rest) for the sustained attention task in the left posterior superior parietal cortex and parieto-occipital junction (BA 7/19). The magnitude of drug-related deactivation of this area during task performance was correlated with improvement in RT. CONCLUSION: Suppression of activity in this area during task performance may reflect a compensatory mechanism by which MPH ameliorates attention impairments in TBI.
Authors: J S Damoiseaux; S A R B Rombouts; F Barkhof; P Scheltens; C J Stam; S M Smith; C F Beckmann Journal: Proc Natl Acad Sci U S A Date: 2006-08-31 Impact factor: 11.205
Authors: Craig W Berridge; David M Devilbiss; Matthew E Andrzejewski; Amy F T Arnsten; Ann E Kelley; Brooke Schmeichel; Christina Hamilton; Robert C Spencer Journal: Biol Psychiatry Date: 2006-06-23 Impact factor: 13.382
Authors: Junghoon Kim; Brian Avants; Sunil Patel; John Whyte; Branch H Coslett; John Pluta; John A Detre; James C Gee Journal: Neuroimage Date: 2007-10-13 Impact factor: 6.556
Authors: Jeffery N Epstein; B J Casey; Simon T Tonev; Matthew C Davidson; Allan L Reiss; Amy Garrett; Stephen P Hinshaw; Laurence L Greenhill; Gary Glover; Keith M Shafritz; Alan Vitolo; Lisa A Kotler; Matthew A Jarrett; Julie Spicer Journal: J Child Psychol Psychiatry Date: 2007-09 Impact factor: 8.982
Authors: Elisabeth A Wilde; Sylvain Bouix; David F Tate; Alexander P Lin; Mary R Newsome; Brian A Taylor; James R Stone; James Montier; Samuel E Gandy; Brian Biekman; Martha E Shenton; Gerald York Journal: Brain Imaging Behav Date: 2015-09 Impact factor: 3.978
Authors: Elizabeth LeBlond; Julia Smith-Paine; Jacqlyn J Riemersma; Paul S Horn; Shari L Wade; Brad G Kurowski Journal: J Int Neuropsychol Soc Date: 2019-08 Impact factor: 2.892
Authors: Samuel S Shin; James W Bales; Hong Q Yan; Anthony E Kline; Amy K Wagner; James Lyons-Weiler; C Edward Dixon Journal: J Neurotrauma Date: 2013-02-05 Impact factor: 5.269
Authors: Scott J Moeller; Anna B Konova; Dardo Tomasi; Muhammad A Parvaz; Rita Z Goldstein Journal: Psychopharmacology (Berl) Date: 2016-05-06 Impact factor: 4.530
Authors: Jacob B Leary; Corina O Bondi; Megan J LaPorte; Lauren J Carlson; Hannah L Radabaugh; Jeffrey P Cheng; Anthony E Kline Journal: J Neurotrauma Date: 2016-05-09 Impact factor: 5.269
Authors: Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer Journal: J Neurotrauma Date: 2014-01-15 Impact factor: 5.269